The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Radioimmunotherapy efficiency and safety in consolidation and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: An updated analysis of 230 patients of the international RIT-network.
Karin Hohloch
Research Funding - Bayer
Henrike Katharina Lankeit
No relevant relationships to disclose
Pier Luigi Zinzani
No relevant relationships to disclose
Michael Lorsbach
No relevant relationships to disclose
Christiane Windemuth-Kiesselbach
No relevant relationships to disclose
Lorenz H. Trumper
Research Funding - Bayer